Issue 62, 2017

Acyclic cucurbit[n]uril conjugated dextran for drug encapsulation and bioimaging

Abstract

An acyclic cucurbit[n]uril (CB[n]) conjugated dextran is developed as a new biomaterial for drug delivery and bioimaging. This biomaterial retains the host–guest recognition properties of acyclic CB[n]s. It is able to directly encapsulate anti-tumor drugs 5-fluorouracil and temozolomide. This polymeric material can form a supramolecular assembly with polyethyleneimine (PEI). Although there is no conventional chromophore in these supramolecular systems, they exhibit aggregation-induced emission (AIE) in water with a quantum yield of 10%. This supramolecular assembly is used for bioimaging in vitro with good biocompatibility.

Graphical abstract: Acyclic cucurbit[n]uril conjugated dextran for drug encapsulation and bioimaging

Supplementary files

Article information

Article type
Communication
Submitted
12 Jun 2017
Accepted
11 Jul 2017
First published
11 Jul 2017

Chem. Commun., 2017,53, 8739-8742

Acyclic cucurbit[n]uril conjugated dextran for drug encapsulation and bioimaging

J. Chen, Y. Liu, D. Mao and D. Ma, Chem. Commun., 2017, 53, 8739 DOI: 10.1039/C7CC04535B

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements